Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,447 | 314,850 | 350,129 | 425,999 | 401,052 |
| Marketable Securities | 848,495 | 521,109 | 437,645 | 197,824 | 180,286 |
| Receivables | 278,637 | 198,524 | 4,920 | 68,644 | 43,450 |
| Inventories | 251,016 | 496,349 | 33,665 | 524 | N/A |
| Income taxes - deferred | 86,880 | 123,945 | 27,675 | 8,771 | N/A |
| Other current assets | 256,569 | 183,887 | 123,576 | 0 | 0 |
| TOTAL | $1,931,044 | $1,838,664 | $977,610 | $708,814 | $631,258 |
| Non-Current Assets | |||||
| PPE Net | 1,525,225 | 1,252,783 | 264,537 | 108,588 | 47,514 |
| Investments And Advances | 1,265,557 | 1,622,620 | 700,565 | 252,051 | 169,188 |
| Intangibles | 4,443,932 | 4,789,878 | 9,280 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 107,697 | 71,763 | 8,446 |
| TOTAL | $7,234,714 | $7,665,281 | $1,082,079 | $432,402 | $225,148 |
| Total Assets | $9,165,758 | $9,503,945 | $2,059,689 | $1,141,216 | $856,406 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 121,471 | 63,364 | 3,886 | 3,866 | 1,737 |
| Accrued Expenses | 247,802 | 240,130 | 51,607 | 27,616 | 16,071 |
| TOTAL | $1,260,748 | $404,825 | $56,225 | $33,789 | $23,045 |
| Non-Current Liabilities | |||||
| Long Term Debt | 101,879 | 887,270 | 866,205 | 135,977 | 128,888 |
| Deferred Revenues | 13,695 | 7,155 | 732 | 2,307 | 4,494 |
| Other Non-Current Liabilities | 54,959 | 50,204 | 27,569 | 12,118 | 1,482 |
| TOTAL | $1,078,609 | $2,045,792 | $893,774 | $150,948 | $138,742 |
| Total Liabilities | $2,339,357 | $2,450,617 | $949,999 | $184,737 | $161,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 344,027 | 331,997 | 154,677 | 152,958 | N/A |
| Common Shares | 173 | 166 | 78 | 76 | 73 |
| Retained earnings | -801,094 | -611,921 | 263,176 | 115,086 | 13,427 |
| Other shareholders' equity | -42,657 | -1,087 | 3,764 | 1,085 | 517 |
| TOTAL | $6,826,401 | $7,053,328 | $1,109,690 | $956,479 | $694,619 |
| Total Liabilities And Equity | $9,165,758 | $9,503,945 | $2,059,689 | $1,141,216 | $856,406 |